Rtw Investments »

Sagimet Biosciences Inc-a shares owned by Rtw Investments

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Rtw Investments

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.5M 400k 8.80

More positions owned by Rtw Investments

Rocket Pharmaceuticals (RCKT)
Immunocore Hldgs Ads (IMCR)
Axsome Therapeutics (AXSM)
Alnylam Pharmaceuticals (ALNY)
Mirati Therapeutics
Argenx Se Sponsored Adr (ARGX)
ACADIA Pharmaceuticals (ACAD)
Bruker Corporation (BRKR)
Ultragenyx Pharmaceutical (RARE)
Penumbra (PEN)
Ptc Therapeutics I (PTCT)
Thermo Fisher Scientific (TMO)
Masimo Corporation (MASI)
Establishment Labs Holdings Ord (ESTA)
Natera (NTRA)

View all positions for Rtw Investments

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Hillhouse Capital Advisors
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rock Springs Capital Management
Artal Group
Partner Fund Management
Millennium Management
Ikarian Capital
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a